By 2030, it is projected that over 60% of the global population will reside in the Asia-Pacific region, with one in four individuals aged 60 or older1. This demographic shift, coupled with rising healthcare costs, an increase in chronic diseases, and a more discerning healthcare consumer base, is driving exceptional growth in the region’s healthcare market.
This evolving landscape presents significant opportunities for the healthcare sector to develop and introduce innovations tailored to the specific health challenges prevalent in Asia-Pacific.
In response, governments across the region are actively investing in initiatives that support the research, development, and commercialisation of advanced medical technologies. A growing number of early-stage companies, often emerging from leading academic institutions, are contributing to this dynamic ecosystem.
Despite this progress, industry research frequently highlights key gaps among early-stage companies and academic innovators:
- A limited understanding of the diverse skill sets required at each stage of the development pathway for medical technologies.
- Insufficient knowledge of regulatory requirements governing the design, development, manufacturing, and global commercialisation of medical devices.
Achieving sustained commercial success in the medical device and medical technology sector demands a strong foundation in regulatory knowledge and ongoing professional development—an area closely aligned with SeerPharma’s mission and core expertise.
Understanding the regulatory landscape is critical when designing and developing new medical devices, as it directly influences the pathway to market.
SeerPharma invites you to join our upcoming webinar, where we will explore the various routes to commercialisation for medical devices and discuss the Quality Management System (QMS) and regulatory requirements essential for market entry.
Wednesday 18th June 2025 | 12pm AEST | 10am SGT
1. https://apacmed.org/the-medtech-industry/medtech-industry-in-apac/
